Radiocontrast substances have a significant role in x-ray diagnosis of urological diseases. Diagnostic and cost-effect efficacy, delivery, storage life are described for radiocontrast substance triombrast (sodium amidotrizoate) of Ukraine production (Kiev). The review was based on the authors' experience and results of clinical trials.